Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]
2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]
Vascular Closure Devices (DO NOT EDIT)[1]
| Class I
|
| “1. Patients considered for vascular closure devices should undergo a femoral angiogram to ensure their anatomic suitability for deployment. (Level of Evidence: C)”
|
| Class IIa
|
| “1. The use of vascular closure devices is reasonable for the purposes of achieving faster hemostasis and earlier ambulation compared with the use of manual compression.[2][3][4][5] (Level of Evidence: B)”
|
References
References
- ↑ 1.0 1.1 Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions” (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08.
- ↑ 2.0 2.1 Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A (2010). “Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty”. American Heart Journal. 159 (4): 518–31. doi:10.1016/j.ahj.2009.12.027. PMID 20362708. Retrieved 2011-12-16.
- ↑ 3.0 3.1 Dauerman HL, Applegate RJ, Cohen DJ (2007). “Vascular closure devices: the second decade”. Journal of the American College of Cardiology. 50 (17): 1617–26. doi:10.1016/j.jacc.2007.07.028. PMID 17950141. Retrieved 2011-12-16.
- ↑ 4.0 4.1 Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M (2004). “Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis”. JAMA : the Journal of the American Medical Association. 291 (3): 350–7. doi:10.1001/jama.291.3.350. PMID 14734598. Retrieved 2011-12-16.
- ↑ 5.0 5.1 Patel MR, Jneid H, Derdeyn CP, Klein LW, Levine GN, Lookstein RA, White CJ, Yeghiazarians Y, Rosenfield K (2010). “Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association”. Circulation. 122 (18): 1882–93. doi:10.1161/CIR.0b013e3181f9b345. PMID 20921445. Retrieved 2011-12-16.
- ↑ Hoffer EK, Bloch RD (2003). “Percutaneous arterial closure devices”. Journal of Vascular and Interventional Radiology : JVIR. 14 (7): 865–85. PMID 12847195.
- ↑ Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G (2004). “Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis”. Journal of the American College of Cardiology. 44 (6): 1200–9. doi:10.1016/j.jacc.2004.06.048. PMID 15364320. Retrieved 2011-12-16.
Template:WH
Template:WS
